Free Trial
NYSE:BMR

Biomed Realty Trust (BMR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$4.71
$4.91
50-Day Range
N/A
52-Week Range
$17.94
$25.08
Volume
119,926 shs
Average Volume
3.29 million shs
Market Capitalization
$62.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BMR stock logo

About Biomed Realty Trust Stock (NYSE:BMR)

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

BMR Stock News Headlines

J.P. Morgan’s DIRE Warning
When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."
7 Stealthy Stocks Ready to Dominate the Market
SGIC Strategic Realty Trust, Inc.
J.P. Morgan’s DIRE Warning
When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."
See More Headlines
Receive BMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomed Realty Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/28/2015
Today
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
Office REITs
CUSIP
09063H10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.91 million
Book Value
$0.80 per share

Miscellaneous

Free Float
N/A
Market Cap
$62.47 million
Optionable
Not Optionable
Beta
5.22
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Greg N. Lubushkin (Age 62)
    Chief Financial Officer
  • James R. Berens (Age 61)
    President of Wexford Science & Technology
  • Jonathan Paul Klassen (Age 39)
    Executive Vice President, General Counsel, Secretary
  • John P. Bonanno (Age 49)
    Executive Vice President, Leasing & Development
  • Karen A. Sztraicher (Age 51)
    Executive Vice President - Asset Management

BMR Stock Analysis - Frequently Asked Questions

How were Biomed Realty Trust's earnings last quarter?

Biomed Realty Trust Inc (NYSE:BMR) announced its earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.04. The company's revenue for the quarter was up 5.4% compared to the same quarter last year.

When did Biomed Realty Trust IPO?

Biomed Realty Trust (BMR) raised $8 million in an initial public offering on Tuesday, February 28th 2023. The company issued 1,950,000 shares at $4.00 per share.

What other stocks do shareholders of Biomed Realty Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Biomed Realty Trust investors own include Gilead Sciences (GILD), Intel (INTC), Kinder Morgan (KMI), Ventas (VTR), Verizon Communications (VZ), Welltower (WELL) and Archer-Daniels-Midland (ADM).

This page (NYSE:BMR) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners